European Archives - Page 209 of 1449 - European Medical Journal

AI-Enhanced Approaches to Interstitial Lung Disease

Explore how machine learning is revolutionising interstitial lung disease management, enhancing early diagnosis, treatment, and prognosis, especially for idiopathic pulmonary fibrosis.

Tirzepatide Diet-related quality of life

Tirzepatide May Boost Diet-Related Quality of Life in Diabetes

Learn how tirzepatide treatment improves diet-related quality of life and satisfaction in Type 2 diabetes patients.

Standardising Patch Testing for Children with Contact Dermatitis

Findings revealed that 17 allergens, already part of the adult EBS, produced positive reactions in at least 1% of children.

Two doctors discussing social media, with one holding an iPad

Social media: What pharma needs to know in 2025

From listening in real time to outpacing the algorithm, these four trends show how marketers can succeed on social.

25 Sep 2025

PERMIT Study: Perampanel as Early Add-On

Epilepsy is a common neurological condition that results from abnormal electrical activity in the brain and is characterised by recurrent…

Resistance Training Improves Health Outcomes in Liver Cirrhosis

Discover a study showing how resistance training can improve inflammation, oxidative stress, and physical performance in patients with liver cirrhosis.

Study Reveals Age, Immunity and Treatment Shape Encephalitis Prognosis

Half of critically ill encephalitis patients face poor outcomes within months, but recovery varies by cause. Keep reading to learn more.

Luis Paz-Ares Chair of the Medical Oncology Department at Hospital Universitario, Madrid

Onc Now: Episode 26: The Evolving Science of Lung Cancer Care

How is scientific innovation is transforming the latest in lung cancer research and care. Chair of the Medical Oncology Department at Hospital Universitario, Luis Paz-Ares, talks about from prevention to emerging treatments in lung cancer.

Immune Response Profiles May Guide Future COVID-19 Booster Use

Immune profiles after COVID-19 vaccination predict booster need, with rapid-decliners at higher risk of breakthrough infection.

Left Atrial Volume at MRI Predicts Heart Outcomes

Discover how LAVImin measured by cardiac MRI outperformed traditional risk factors in predicting adverse outcomes after heart attack, offering a new biomarker for patient risk assessment.